Follow the people · Insider
Willis C. Lee
Willis C. Lee files insider transactions with the SEC as a ceo of Emmaus Life Sciences (EMMA). We hold 6 disclosed purchases and sales filed since 7 October 2011, 6 of them in the last 90 days.
- Files forEMMA
- Disclosed buys and sells6 in all, 6 in the last 90 days
- Last disclosure2 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 May 2016 — 31 August 2026CEO · Emmaus Life Sciences (EMMA)95 Form 4 lines · source: SEC Form 4
- Filed 2 April 2012 — 2 October 2014Chief Operating Officer · Emmaus Life Sciences (NONE)10 Form 4 lines · source: SEC Form 4
- Filed 5 October 2011 — 5 October 2011Chief Operating Officer · Emmaus Life Sciences ([NONE])2 Form 4 lines · source: SEC Form 4
Everything they disclosed
107 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 70,000 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 30 May 2025 · filed 2 September 2026
- ▲ bought on the open market 170,000 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 29 August 2025 · filed 2 September 2026
- ▲ bought on the open market 46,000 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 25 August 2026 · filed 2 September 2026
- ▲ bought on the open market 50,000 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 27 August 2026 · filed 2 September 2026
- ▲ bought on the open market 94,767 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 28 August 2026 · filed 2 September 2026
- ▲ bought on the open market 100,000 shares of Emmaus Life SciencesSEC Form 42 September 2026Common stock, $0.001 par value · traded 31 August 2026 · filed 2 September 2026
- ▲ bought on the open market 13,200 shares of Emmaus Life SciencesSEC Form 429 February 2024Common stock, $0.001 par value · traded 26 February 2024 · filed 29 February 2024
- ▲ bought on the open market 10,000 shares of Emmaus Life SciencesSEC Form 429 February 2024Common stock, $0.001 par value · traded 27 February 2024 · filed 29 February 2024
- ▲ bought on the open market 15,000 shares of Emmaus Life SciencesSEC Form 429 February 2024Common stock, $0.001 par value · traded 28 February 2024 · filed 29 February 2024
- ▲ bought on the open market 77,000 shares of Emmaus Life SciencesSEC Form 429 February 2024Common stock, $0.001 par value · traded 29 February 2024 · filed 29 February 2024
- was granted 200,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 45 February 2024Options · traded 1 February 2024 · filed 5 February 2024
- ▲ bought on the open market 6,500 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 25 August 2023 · filed 3 January 2024
- ▲ bought on the open market 6,000 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 31 August 2023 · filed 3 January 2024
- ▲ bought on the open market 1,100 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 14 November 2023 · filed 3 January 2024
- ▲ bought on the open market 12,000 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 28 November 2023 · filed 3 January 2024
- ▲ bought on the open market 36,000 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 29 November 2023 · filed 3 January 2024
- ▲ bought on the open market 59,400 shares of Emmaus Life SciencesSEC Form 43 January 2024Common stock, $0.001 par value · traded 30 November 2023 · filed 3 January 2024
- ▲ bought on the open market 1,365 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 25 August 2023 · filed 4 December 2023
- ▲ bought on the open market 900 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 31 August 2023 · filed 4 December 2023
- ▲ bought on the open market 132 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 14 November 2023 · filed 4 December 2023
- ▲ bought on the open market 1,470 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 28 November 2023 · filed 4 December 2023
- ▲ bought on the open market 4,325 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 29 November 2023 · filed 4 December 2023
- ▲ bought on the open market 7,417 shares of Emmaus Life SciencesSEC Form 44 December 2023Common stock, $0.001 par value · traded 30 November 2023 · filed 4 December 2023
- ▲ bought on the open market 750 shares of Emmaus Life SciencesSEC Form 42 June 2023Common stock, $0.001 par value · traded 20 September 2022 · filed 2 June 2023
- ▲ bought on the open market 28,700 shares of Emmaus Life SciencesSEC Form 42 June 2023Common stock, $0.001 par value · traded 31 May 2023 · filed 2 June 2023
- was granted 500,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 419 January 2023Options · traded 12 January 2023 · filed 19 January 2023
- was granted 750,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 417 January 2023Options · traded 12 January 2023 · filed 17 January 2023
- ▲ bought on the open market 3,200 shares of Emmaus Life SciencesSEC Form 425 July 2022Common stock, $0.001 par value · traded 19 July 2022 · filed 25 July 2022
- ▲ bought on the open market 2,500 shares of Emmaus Life SciencesSEC Form 43 June 2022Common stock, $0.001 par value · traded 27 May 2022 · filed 3 June 2022
- ▲ bought on the open market 2,500 shares of Emmaus Life SciencesSEC Form 43 June 2022Common stock, $0.001 par value · traded 31 May 2022 · filed 3 June 2022
- ▲ bought on the open market 3,200 shares of Emmaus Life SciencesSEC Form 412 April 2022Common stock, $0.001 par value · traded 4 April 2022 · filed 12 April 2022
- ▲ bought on the open market 1,400 shares of Emmaus Life SciencesSEC Form 412 April 2022Common stock, $0.001 par value · traded 6 April 2022 · filed 12 April 2022
- ▲ bought on the open market 1,600 shares of Emmaus Life SciencesSEC Form 412 April 2022Common stock, $0.001 par value · traded 8 April 2022 · filed 12 April 2022
- ▲ bought on the open market 8,900 shares of Emmaus Life SciencesSEC Form 412 April 2022Common stock, $0.001 par value · traded 11 April 2022 · filed 12 April 2022
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 428 February 2022Common stock, $0.001 par value · traded 22 February 2022 · filed 28 February 2022
- ▲ bought on the open market 5,900 shares of Emmaus Life SciencesSEC Form 428 February 2022Common stock, $0.001 par value · traded 24 February 2022 · filed 28 February 2022
- ▲ bought on the open market 7,200 shares of Emmaus Life SciencesSEC Form 428 February 2022Common stock, $0.001 par value · traded 28 February 2022 · filed 28 February 2022
- ▲ bought on the open market 6,600 shares of Emmaus Life SciencesSEC Form 428 February 2022Common stock, $0.001 par value · traded 28 February 2022 · filed 28 February 2022
- ▲ bought on the open market 900 shares of Emmaus Life SciencesSEC Form 428 February 2022Common stock, $0.001 par value · traded 28 February 2022 · filed 28 February 2022
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 45 January 2022Common stock, $0.001 par value · traded 3 December 2021 · filed 5 January 2022
- ▲ bought on the open market 200 shares of Emmaus Life SciencesSEC Form 45 January 2022Common stock, $0.001 par value · traded 10 December 2021 · filed 5 January 2022
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 45 January 2022Common stock, $0.001 par value · traded 13 December 2021 · filed 5 January 2022
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 45 January 2022Common stock, $0.001 par value · traded 17 December 2021 · filed 5 January 2022
- ▲ bought on the open market 24,328 shares of Emmaus Life SciencesSEC Form 430 November 2021Common stock, $0.001 par value · traded 26 November 2021 · filed 30 November 2021
- ▲ bought on the open market 15,705 shares of Emmaus Life SciencesSEC Form 430 November 2021Common stock, $0.001 par value · traded 29 November 2021 · filed 30 November 2021
- ▲ bought on the open market 15,500 shares of Emmaus Life SciencesSEC Form 430 November 2021Common stock, $0.001 par value · traded 30 November 2021 · filed 30 November 2021
- ▲ bought on the open market 3,500 shares of Emmaus Life SciencesSEC Form 426 November 2021Common stock, $0.001 par value · traded 23 November 2021 · filed 26 November 2021
- ▲ bought on the open market 34,500 shares of Emmaus Life SciencesSEC Form 426 November 2021Common stock, $0.001 par value · traded 24 November 2021 · filed 26 November 2021
- ▲ bought on the open market 1,600 shares of Emmaus Life SciencesSEC Form 423 November 2021Common stock, $0.001 par value · traded 15 November 2021 · filed 23 November 2021
- ▲ bought on the open market 2,100 shares of Emmaus Life SciencesSEC Form 423 November 2021Common stock, $0.001 par value · traded 16 November 2021 · filed 23 November 2021
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 423 November 2021Common stock, $0.001 par value · traded 17 November 2021 · filed 23 November 2021
- ▲ bought on the open market 5,000 shares of Emmaus Life SciencesSEC Form 423 November 2021Common stock, $0.001 par value · traded 19 November 2021 · filed 23 November 2021
- ▲ bought on the open market 8,900 shares of Emmaus Life SciencesSEC Form 423 November 2021Common stock, $0.001 par value · traded 22 November 2021 · filed 23 November 2021
- ▲ bought on the open market 2,000 shares of Emmaus Life SciencesSEC Form 417 September 2021Common stock, $0.001 par value · traded 15 September 2021 · filed 17 September 2021
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 417 September 2021Common stock, $0.001 par value · traded 16 September 2021 · filed 17 September 2021
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 417 September 2021Common stock, $0.001 par value · traded 17 September 2021 · filed 17 September 2021
- ▲ bought on the open market 2,000 shares of Emmaus Life SciencesSEC Form 410 September 2021Common stock, $0.001 par value · traded 8 September 2021 · filed 10 September 2021
- ▲ bought on the open market 2,000 shares of Emmaus Life SciencesSEC Form 410 September 2021Common stock, $0.001 par value · traded 10 September 2021 · filed 10 September 2021
- ▲ bought on the open market 2,400 shares of Emmaus Life SciencesSEC Form 427 August 2021Common stock, $0.001 par value · traded 25 August 2021 · filed 27 August 2021
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 427 August 2021Common stock, $0.001 par value · traded 26 August 2021 · filed 27 August 2021
- ▲ bought on the open market 1,500 shares of Emmaus Life SciencesSEC Form 427 August 2021Common stock, $0.001 par value · traded 27 August 2021 · filed 27 August 2021
- ▲ bought on the open market 2,700 shares of Emmaus Life SciencesSEC Form 428 May 2021Common stock, $0.001 par value · traded 26 May 2021 · filed 28 May 2021
- ▲ bought on the open market 2,000 shares of Emmaus Life SciencesSEC Form 428 May 2021Common stock, $0.001 par value · traded 27 May 2021 · filed 28 May 2021
- ▲ bought on the open market 3,900 shares of Emmaus Life SciencesSEC Form 428 May 2021Common stock, $0.001 par value · traded 28 May 2021 · filed 28 May 2021
- ▲ bought on the open market 1,500 shares of Emmaus Life SciencesSEC Form 412 May 2021Common stock, $0.001 par value · traded 10 May 2021 · filed 12 May 2021
- ▲ bought on the open market 13,350 shares of Emmaus Life SciencesSEC Form 412 May 2021Common stock, $0.001 par value · traded 12 May 2021 · filed 12 May 2021
- ▲ bought on the open market 2,500 shares of Emmaus Life SciencesSEC Form 47 May 2021Common stock, $0.001 par value · traded 5 May 2021 · filed 7 May 2021
- ▲ bought on the open market 1,500 shares of Emmaus Life SciencesSEC Form 47 May 2021Common stock, $0.001 par value · traded 7 May 2021 · filed 7 May 2021
- ▲ bought on the open market 6,000 shares of Emmaus Life SciencesSEC Form 415 October 2020Common stock, $0.001 par value · traded 13 October 2020 · filed 15 October 2020
- ▲ bought on the open market 1,600 shares of Emmaus Life SciencesSEC Form 415 October 2020Common stock, $0.001 par value · traded 14 October 2020 · filed 15 October 2020
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 41 April 2020Common stock, $0.001 par value · traded 30 March 2020 · filed 1 April 2020
- ▲ bought on the open market 4,000 shares of Emmaus Life SciencesSEC Form 41 April 2020Common stock, $0.001 par value · traded 31 March 2020 · filed 1 April 2020
- ▲ bought on the open market 3,500 shares of Emmaus Life SciencesSEC Form 430 March 2020Common stock, $0.001 par value · traded 26 March 2020 · filed 30 March 2020
- ▲ bought on the open market 3,300 shares of Emmaus Life SciencesSEC Form 430 March 2020Common stock, $0.001 par value · traded 27 March 2020 · filed 30 March 2020
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 425 March 2020Common stock, $0.001 par value · traded 23 March 2020 · filed 25 March 2020
- ▲ bought on the open market 500 shares of Emmaus Life SciencesSEC Form 425 March 2020Common stock, $0.001 par value · traded 24 March 2020 · filed 25 March 2020
- ▲ bought on the open market 3,050 shares of Emmaus Life SciencesSEC Form 419 March 2020Common stock, $0.001 par value · traded 17 March 2020 · filed 19 March 2020
- ▲ bought on the open market 3,500 shares of Emmaus Life SciencesSEC Form 419 March 2020Common stock, $0.001 par value · traded 18 March 2020 · filed 19 March 2020
- ▲ bought on the open market 1,300 shares of Emmaus Life SciencesSEC Form 412 March 2020Common stock, $0.001 par value · traded 10 March 2020 · filed 12 March 2020
- ▲ bought on the open market 1,200 shares of Emmaus Life SciencesSEC Form 412 March 2020Common stock, $0.001 par value · traded 11 March 2020 · filed 12 March 2020
- ▲ bought on the open market 1,650 shares of Emmaus Life SciencesSEC Form 49 March 2020Common stock, $0.001 par value · traded 5 March 2020 · filed 9 March 2020
- ▲ bought on the open market 9,500 shares of Emmaus Life SciencesSEC Form 49 March 2020Common stock, $0.001 par value · traded 9 March 2020 · filed 9 March 2020
- ▲ bought on the open market 1,900 shares of Emmaus Life SciencesSEC Form 414 February 2020Common stock, $0.001 par value · traded 12 February 2020 · filed 14 February 2020
- ▲ bought on the open market 1,100 shares of Emmaus Life SciencesSEC Form 414 February 2020Common stock, $0.001 par value · traded 13 February 2020 · filed 14 February 2020
- ▲ bought on the open market 1,950 shares of Emmaus Life SciencesSEC Form 410 February 2020Common stock, $0.001 par value · traded 6 February 2020 · filed 10 February 2020
- ▲ bought on the open market 2,600 shares of Emmaus Life SciencesSEC Form 410 February 2020Common stock, $0.001 par value · traded 7 February 2020 · filed 10 February 2020
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 41 November 2019Common stock, $0.001 par value · traded 31 October 2019 · filed 1 November 2019
- ▲ bought on the open market 800 shares of Emmaus Life SciencesSEC Form 41 November 2019Common stock, $0.001 par value · traded 1 November 2019 · filed 1 November 2019
- ▲ bought on the open market 4,000 shares of Emmaus Life SciencesSEC Form 418 October 2019Common stock, $0.001 par value · traded 16 October 2019 · filed 18 October 2019
- ▲ bought on the open market 3,890 shares of Emmaus Life SciencesSEC Form 418 October 2019Common stock, $0.001 par value · traded 18 October 2019 · filed 18 October 2019
- ▲ bought on the open market 4,000 shares of Emmaus Life SciencesSEC Form 416 October 2019Common stock, $0.001 par value · traded 14 October 2019 · filed 16 October 2019
- ▲ bought on the open market 7,000 shares of Emmaus Life SciencesSEC Form 416 October 2019Common stock, $0.001 par value · traded 15 October 2019 · filed 16 October 2019
- ▲ bought on the open market 600 shares of Emmaus Life SciencesSEC Form 429 August 2019Common stock, $0.001 par value · traded 27 August 2019 · filed 29 August 2019
- ▲ bought on the open market 1,000 shares of Emmaus Life SciencesSEC Form 423 August 2019Common stock, $0.001 par value · traded 21 August 2019 · filed 23 August 2019
- was granted 300,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 412 May 2016Incentive Stock Options · traded 10 May 2016 · filed 12 May 2016
- exercised options over 35,556 shares of Emmaus Life SciencesSEC Form 46 October 2014Common Stock · traded 2 October 2014 · filed 6 October 2014
- exercised options over 36,588 shares of Emmaus Life SciencesSEC Form 46 October 2014Common Stock · traded 2 October 2014 · filed 6 October 2014
- exercised options over 35,556 shares of Emmaus Life Sciences (a derivative holding)SEC Form 46 October 2014Common Stock Warrant · traded 2 October 2014 · filed 6 October 2014
- exercised options over an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 46 October 2014Convertible Promissory Note · traded 2 October 2014 · filed 6 October 2014
- returned to the issuer an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 46 October 2014Convertible Promissory Note · traded 2 October 2014 · filed 6 October 2014
- acquired or disposed of, other an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 412 November 2013Convertible Promissory Note · traded 8 November 2013 · filed 12 November 2013
- was granted an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 412 November 2013Convertible Promissory Note · traded 12 November 2013 · filed 12 November 2013
- acquired or disposed of, other 500,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 417 May 2013Convertible Promissory Note · traded 5 October 2012 · filed 17 May 2013
- was granted an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 417 May 2013Incentive Stock Options · traded 28 February 2013 · filed 17 May 2013
- was granted 250,000 shares of Emmaus Life Sciences (a derivative holding)SEC Form 44 April 2012Incentive Stock Options · traded 2 April 2012 · filed 4 April 2012
- acquired or disposed of, other 35,556 shares of Emmaus Life Sciences (a derivative holding)SEC Form 47 October 2011Convertible Promissory Note · traded 5 October 2011 · filed 7 October 2011
- acquired or disposed of, other an unstated number of shares of Emmaus Life Sciences (a derivative holding)SEC Form 47 October 2011Warrant · traded 5 October 2011 · filed 7 October 2011
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.